That news comes as the rating agency downgraded the seven-hospital system’s outstanding debt from “BBB+” to “BBB.” The outlook is negative.
“The downgrade reflects Nuvance’s significant operating losses and diminished unrestricted reserves that provide limited cushion even at the current rating,” said S&P Global Ratings credit analyst Anne Cosgrove.
Nuvance Health was similarly downgraded in July by Moody’s, which warned that the system faced a “pivotal” next several quarters. The system had $2.6 billion in revenue in 2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
